Found 118 matching trials
40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) PHASE3 Bipolar disorder is characterized by mood swings that range from from high ...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine PHASE1 This Phase 1b Study RDX-002-22-09 has been planned to evaluate the effect o...
Show More Learn More & Join Trial
Study of the Breast Milk Pharmacokinetics of Olanzapine and Samidorphan PHASE1 This clinical lactation study is to provide information regarding the PK an...
Show More Location
Alkermes Investigator Site
Learn More & Join Trial
A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia PHASE3 The purpose of this 6 month study is to compare the metabolic effects of pa...
Show More Location
Multiple Locations
Learn More & Join Trial
Olanzapine for the Prevention of Postoperative Nausea and Vomiting PHASE1 Nausea and vomiting (PONV) remain a common problem in surgical units. Even ...
Show More Location
Assiut university hospitals
Learn More & Join Trial
Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784) PHASE3 Schizophrenia is a brain disease. The primary features of schizophrenia are...
Show More Location
Multiple Locations
Learn More & Join Trial
Switching to Iloperidone From Other Antipsychotics in Schizophrenia PHASE4 Evaluate the clinical outcome of two switching strategies to iloperidone tr...
Show More Location
Birmingham Psychiatry Pharmaceutical Studies, Inc.
Learn More & Join Trial
Cardio Risk of Acute Schizophrenia Olanzapine Duke PHASE4 Primary Objective: To compare added metformin and/or added simvastatin vers...
Show More Location
John Umstead Hospital
Learn More & Join Trial
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression PHASE4 The main goal of this study is to help answer the following research questi...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients PHASE3 The objective of this study is to investigate the efficacy of olanzapine as...
Show More Location
University of Michigan Rogel Cancer Center
Learn More & Join Trial